Morphic Holding, Inc. (MORF) Financials
Stock symbol MORF is outdated, potentially delisted? Maybe it is available on other exchange?
MORF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 646.1 million | 27.7 million |
| March 31, 2024 | 682.8 million | 19.2 million |
| Dec. 31, 2023 | 722.5 million | 25.5 million |
| Sept. 30, 2023 | 743.6 million | 20.4 million |
MORF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -32.4 million | 13.2 million |
| March 31, 2024 | -47.1 million | 13.4 million |
| Dec. 31, 2023 | -28.7 million | 10.5 million |
| Sept. 30, 2023 | -29.6 million | 10.5 million |
MORF Net Income
No data available :(
MORF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 628.4 million | 1.2 million | 1.2 million |
| March 31, 2024 | 658.8 million | 1.5 million | 1.5 million |
| Dec. 31, 2023 | 704.3 million | 716000 | 2.3 million |
| Sept. 30, 2023 | 725.1 million | 1.1 million | 2.7 million |
MORF Shares Outstanding
MORF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | 275000 | 49.0 million | 16.0 million | - |
| March 31, 2024 | 674000 | 42.2 million | 11.2 million | - |
| Dec. 31, 2023 | 93000 | 39.9 million | 9.6 million | - |
| Sept. 30, 2023 | 305000 | 34.4 million | 10.4 million | - |
MORF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | - | 275000 |
| March 31, 2024 | - | 282000 |
| Dec. 31, 2023 | -60.2 million | 280000 |
| Sept. 30, 2023 | - | 286000 |
MORF Revenue by Segment
Graph available only for paid members. Upgrade to see it.
MORF
Price: $56.99
52 week price:
Earnings Per Share: -3.83 USD
P/E Ratio: -10.56
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 148800
Market Capitalization: 2.9 billion